Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RETAAC in diffuse diabetic macular edema
NCT00407849Phase 2Unknown
- Sponsor
- Federal University of São Paulo
- Start
- Oct 2006
- Primary completion
- Dec 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone in diabetic macular edema (DME), sponsored by Federal University of São Paulo. Status: unknown.
02
Drugs
triamcinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00407849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00407849.